Epidemiology and impact of frailty in patients with atrial fibrillation in Europe.
Marco ProiettiGiulio Francesco RomitiMarco VitoloStephanie L HarrisonDeirdre A LaneLaurent FauchierFrancisco MarinMichael NäbauerTatjana S PotparaGheorghe-Andrei DanAldo Pietro MaggioniMatteo CesariGiuseppe BorianiGregory Y H Lipnull nullPublished in: Age and ageing (2022)
In this large cohort of AF patients, there was a high burden of frailty, influencing clinical management and risk of adverse outcomes. The clinical benefit of OAC is maintained in patients with high frailty, but not in very high/extremely frail ones.